Cabaletta Bio, Inc. CABA
1.42 USD -0.01 (-1.05%)
Nov 3, 2026, 3:16 PM EST
1.40 Day range 1.50
1.32 52-week range 4.23
- YTD
- -35.39%
- 1 year
- -52.99%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 22.22 +1470.5% upside
Now 1.42
- Target (low)
- 6.00
- Target (mean)
- 22.22
- Target (high)
- 35.00
Ratings (0m) 12 10 buy · 2 hold · 0 sell
- Strong buy2
- Buy8
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 12
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.64072 | -0.72646 – -0.45 | -0.46 | -39.3% | 0 | 0.0% | 7 |
| Next quarter | -0.67417 | -0.74 – -0.46 | -0.51 | -32.2% | 0 | 0.0% | 5 |
| Current year | -2.35 | -2.47 – -2.10 | -1.65 | -42.3% | 0 | 0.0% | 8 |
| Next year | -2.66 | -3.25 – -1.84 | -2.35 | -13.1% | 0 | 0.0% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Dec 19, 2024 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Nov 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 15, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 10, 2024 | UBS | Initiated | — | Buy |
| Sep 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 12, 2024 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 9, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 21, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 17, 2024 | Stifel | Maintained | Buy | Buy |
| Jun 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 24, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 5, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Apr 4, 2024 | Citigroup | Maintained | Buy | Buy |
| Mar 22, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 22, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 22, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 5, 2024 | Jefferies | Initiated | — | Buy |
| Nov 29, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 29, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 15, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Nov 10, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 8, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 24, 2023 | Cantor Fitzgerald | Initiated | — | Overweight |
| Oct 19, 2023 | Stifel | Initiated | — | Buy |
| Oct 4, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 18, 2023 | Wells Fargo | Maintained | Overweight | Overweight |